Seattle Children's Hospital

• KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma
• Novel surgical approach for intraventricular cerliponase alfa enzyme replacement therapy via central venous access device (CVAD) port in neuronal ceroid lipofuscinosis type 2 (CLN2) disease
• Artificial intelligence-driven genotype-epigenotype-phenotype approaches to resolve challenges in syndrome diagnostics
• A ventilated perfused lung model platform to dissect the response of the lungs to viral infection
• Physicians' Perceptions of Barriers and Facilitators to the Improvement of Healthcare Equity for Children Hospitalized With Traumatic Brain Injury: Preliminary Findings From a Pilot Multicenter Pediatric Trauma Study From the United States
• Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics
• Outcomes of arteriovenous malformations with single versus multiple draining veins: A multicenter study
• Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes

Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, WA, USA.

https://www.seattlechildrens.org/clinics/neurosciences/services/neurosurgery-program/